Table 1 Clinical features of the 52 cats with sporotrichosis in the first appointment before treatment with itraconazole (T1) and in the appointment between the 5th and 11th week after the beginning of itraconazole treatment (T2).

From: Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis

Clinical features

Classification

Number of cats (n = 52)

pb

T1

T2

Body condition

Good

37

41

0.344

Fair/poor

15

11

 

Distribution of skin lesions

L1/L2

17

34

<0.001*

L3

35

18

 

Number of skin lesions

≤3

23

48

<0.001*

>3

29

4

 

Nasal mucosa lesions

Yes

32

32

1.000

No

20

20

 

Respiratory signsa

Yes

32

32

1.000

No

20

20

 
  1. L1, lesions at one site; L2, lesions at 2 non-contiguous sites; L3, lesions at 3 or more non-contiguous sites; n, total number of cats examined. aSneezing, nasal discharge or dyspnoea; bMcNemar test. *Significant difference (p < 0.05).
Back to article page